Cargando…

Pioglitazone, bladder cancer, and detection bias

Detalles Bibliográficos
Autor principal: Dolin, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282397/
https://www.ncbi.nlm.nih.gov/pubmed/24004505
http://dx.doi.org/10.1111/1753-0407.12087
_version_ 1782351129838878720
author Dolin, Paul
author_facet Dolin, Paul
author_sort Dolin, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-4282397
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42823972015-01-15 Pioglitazone, bladder cancer, and detection bias Dolin, Paul J Diabetes Letter to the Editor BlackWell Publishing Ltd 2014-03 2013-10-31 /pmc/articles/PMC4282397/ /pubmed/24004505 http://dx.doi.org/10.1111/1753-0407.12087 Text en © 2014 Takeda Development Centre Europe Ltd. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Dolin, Paul
Pioglitazone, bladder cancer, and detection bias
title Pioglitazone, bladder cancer, and detection bias
title_full Pioglitazone, bladder cancer, and detection bias
title_fullStr Pioglitazone, bladder cancer, and detection bias
title_full_unstemmed Pioglitazone, bladder cancer, and detection bias
title_short Pioglitazone, bladder cancer, and detection bias
title_sort pioglitazone, bladder cancer, and detection bias
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282397/
https://www.ncbi.nlm.nih.gov/pubmed/24004505
http://dx.doi.org/10.1111/1753-0407.12087
work_keys_str_mv AT dolinpaul pioglitazonebladdercanceranddetectionbias